118 related articles for article (PubMed ID: 17998294)
1. Genetic polymorphisms and haplotype structures of the human CYP2W1 gene in a Japanese population.
Hanzawa Y; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Feb; 36(2):349-52. PubMed ID: 17998294
[TBL] [Abstract][Full Text] [Related]
2. CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk.
Gervasini G; de Murillo SG; Ladero JM; Agúndez JA
Pharmacogenomics; 2010 Jul; 11(7):919-25. PubMed ID: 20602611
[TBL] [Abstract][Full Text] [Related]
3. Novel single nucleotide polymorphisms (SNPs) of CYP2W1 gene in Chinese Uygur and Han populations.
Qi GZ; Wang X; Miao XJ; Yin SJ; Ren H; Lou YQ; Zhang GL
Drug Metab Pharmacokinet; 2015 Dec; 30(6):449-52. PubMed ID: 26683388
[TBL] [Abstract][Full Text] [Related]
4. Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur.
Li Y; Kang X; Yang G; Dai P; Chen C; Wang H
Drug Metab Dispos; 2016 Sep; 44(9):1510-5. PubMed ID: 27307299
[TBL] [Abstract][Full Text] [Related]
5. CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer.
Cárdenas-Rodríguez N; Lara-Padilla E; Bandala C; López-Cruz J; Uscanga-Carmona C; Lucio-Monter PF; Floriano-Sánchez E
Asian Pac J Cancer Prev; 2012; 13(3):837-46. PubMed ID: 22631658
[TBL] [Abstract][Full Text] [Related]
6. Expression of CYP2W1 in colon tumors: regulation by gene methylation.
Gomez A; Karlgren M; Edler D; Bernal ML; Mkrtchian S; Ingelman-Sundberg M
Pharmacogenomics; 2007 Oct; 8(10):1315-25. PubMed ID: 17979506
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Ramón y Cajal S; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Mar; 341(2):451-8. PubMed ID: 16426568
[TBL] [Abstract][Full Text] [Related]
8. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity.
Sata F; Sapone A; Elizondo G; Stocker P; Miller VP; Zheng W; Raunio H; Crespi CL; Gonzalez FJ
Clin Pharmacol Ther; 2000 Jan; 67(1):48-56. PubMed ID: 10668853
[TBL] [Abstract][Full Text] [Related]
9. CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer.
Stenstedt K; Travica S; Guo J; Barragan I; Pors K; Patterson L; Edler D; Mkrtchian S; Johansson I; Ingelman-Sundberg M
Pharmacogenomics; 2013 Oct; 14(13):1615-22. PubMed ID: 24088132
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic properties of human CYP2W1 expressed in Escherichia coli.
Yoshioka H; Kasai N; Ikushiro S; Shinkyo R; Kamakura M; Ohta M; Inouye K; Sakaki T
Biochem Biophys Res Commun; 2006 Jun; 345(1):169-74. PubMed ID: 16677611
[TBL] [Abstract][Full Text] [Related]
11. Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population.
Du J; Xing Q; Xu L; Xu M; Shu A; Shi Y; Yu L; Zhang A; Wang L; Wang H; Li X; Feng G; He L
Pharmacogenomics; 2006 Sep; 7(6):831-41. PubMed ID: 16981844
[TBL] [Abstract][Full Text] [Related]
12. Three novel single nucleotide polymorphisms (SNPs) of CYP2S1 gene in Japanese individuals.
Hanzawa Y; Sasaki T; Hiratsuka M; Ishikawa M; Mizugaki M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):136-40. PubMed ID: 17495422
[TBL] [Abstract][Full Text] [Related]
13. Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.
Maekawa K; Fukushima-Uesaka H; Tohkin M; Hasegawa R; Kajio H; Kuzuya N; Yasuda K; Kawamoto M; Kamatani N; Suzuki K; Yanagawa T; Saito Y; Sawada J
Pharmacogenet Genomics; 2006 Jul; 16(7):497-514. PubMed ID: 16788382
[TBL] [Abstract][Full Text] [Related]
14. Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapy.
Karlgren M; Ingelman-Sundberg M
Expert Opin Ther Targets; 2007 Jan; 11(1):61-7. PubMed ID: 17150034
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population.
Saeki M; Saito Y; Nakamura T; Murayama N; Kim SR; Ozawa S; Komamura K; Ueno K; Kamakura S; Nakajima T; Saito H; Kitamura Y; Kamatani N; Sawada J
Hum Mutat; 2003 Jun; 21(6):653. PubMed ID: 14961555
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms and haplotype structures of the CYP4A22 gene in a Japanese population.
Hiratsuka M; Nozawa H; Katsumoto Y; Moteki T; Sasaki T; Konno Y; Mizugaki M
Mutat Res; 2006 Jul; 599(1-2):98-104. PubMed ID: 16806293
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of bile acid CoA: amino acid N-acyltransferase in Japanese individuals.
Tougou K; Fukuda T; Ito T; Yamazaki H; Fujio Y; Azuma J
Drug Metab Pharmacokinet; 2007 Apr; 22(2):125-8. PubMed ID: 17495420
[TBL] [Abstract][Full Text] [Related]
19. The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population.
Armstrong M; Fairbrother K; Idle JR; Daly AK
Pharmacogenetics; 1994 Apr; 4(2):73-81. PubMed ID: 8081414
[TBL] [Abstract][Full Text] [Related]
20. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
